Jeffrey L. Wade
2017
In 2017, Jeffrey L. Wade earned a total compensation of $1.2M as Executive Vice President, Corporate and Administrative Affairs and Chief Financial Officer at Lexicon Pharmaceuticals, which was about the same as previous year.
Compensation breakdown
| Bonus | $154,963 |
|---|---|
| Option Awards | $459,175 |
| Salary | $427,038 |
| Stock Awards | $161,584 |
| Other | $11,675 |
| Total | $1,214,435 |
Wade received $459.2K in option awards, accounting for 38% of the total pay in 2017.
Wade also received $155K in bonus, $427K in salary, $161.6K in stock awards and $11.7K in other compensation.
Rankings
In 2017, Jeffrey L. Wade's compensation ranked 8,056th out of 14,666 executives tracked by ExecPay. In other words, Wade earned more than 45.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,056 out of 14,666 | 45th |
Division Manufacturing | 3,031 out of 5,768 | 48th |
Major group Chemicals And Allied Products | 995 out of 2,074 | 52nd |
Industry group Drugs | 778 out of 1,730 | 55th |
Industry Pharmaceutical Preparations | 614 out of 1,329 | 54th |
Source: SEC filing on March 16, 2018.
Wade's colleagues
We found four more compensation records of executives who worked with Jeffrey L. Wade at Lexicon Pharmaceuticals in 2017.
2017
Lonnel Coats
Lexicon Pharmaceuticals
Chief Executive Officer
2017
Praveen Tyle
Lexicon Pharmaceuticals
Executive Vice President, Research and Development
2017
Pablo Lapuerta
Lexicon Pharmaceuticals
Chief Medical Officer
2017
Alexander Santini
Lexicon Pharmaceuticals
Executive Vice President and Chief Commercial Officer
News
Lexicon Pharmaceuticals CEO Lonnel Coats' 2023 pay slips 1% to $4.1M
March 26, 2024
Lexicon Pharmaceuticals CEO Lonnel Coats' 2021 pay rises 2% to $3.9M
April 8, 2022
Lexicon Pharmaceuticals CEO Lonnel Coats' 2020 pay stays at $3.9M
March 19, 2021
Lexicon Pharmaceuticals CEO Lonnel Coats' 2019 pay jumps 24% to $3.9M
March 13, 2020
Lexicon Pharmaceuticals CEO Lonnel Coats' 2018 pay jumps 41% to $3.1M
March 14, 2019